De nieuwe handelsdeal van Donald Trump met Xi Jinping zou de situatie kunnen verbeteren voor kiezers – en voor hemzelf.

Western biopharma companies are increasingly turning to China to source innovation, as pharma's dreaded "patent cliff" draws closer.

By Siddharth Cavale NEW YORK, Oct 1 (Reuters) - Oil prices jumped on Thursday and settled up more than $4 a barrel, after a ...

Oct 2 (Reuters) - A US lawmaker has called on Starbucks to close its first stores in China's Xinjiang, calling it a "morally bankrupt decision" to do business in a region where Uyghurs face repression ...

Britain’s MI5 spy agency issued an unprecedented alert on ​Wednesday to warn that a Chinese organization was involved in ...

China's antitrust regulator has asked Anglo American to commit ​to supply the country with a steady flow of copper ...

O nce again Team China has crushed its rivals. At the WorldSkills Competition it won a record 41 gold medals, ten times as ...

China has cut a central bank lending rate and unveiled nationwide subsidies for mortgage interest payments in policymakers’ ...

Novak Djokovic maintained his flawless record at the China Open despite needing a medical timeout during his first round ...